Prognostic factors in the progression of intervertebral disc degeneration: Which patient should be targeted with regenerative therapies?
Abstract Objective Possible regenerative treatments for lumbar intervertebral disc degeneration (DD) are rapidly emerging. There is consensus that the patient that would benefit most has early‐stage DD, with a predicted deterioration in the near future. To identify this patient, the aim of this stud...
Main Authors: | Christine M. E. Rustenburg, Sayf S. A. Faraj, Johannes C. F. Ket, Kaj S. Emanuel, Theodoor H. Smit |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | JOR Spine |
Subjects: | |
Online Access: | https://doi.org/10.1002/jsp2.1063 |
Similar Items
-
The role of infectious pathogens in etiopathogenesis of degenerative intervertebral disc diseases
by: Mark M. Alexanyan, et al.
Published: (2020-06-01) -
DEGENERATIVE INTERVERTEBRAL DISC DISEASE: DIFFICULTIES IN DEFINITION OF THE CONCEPT AND EPIDEMIOLOGY OF THE PHENOMENON. BRIEF COMMUNICATION
by: Volodymyr V. Medvediev, et al.
Published: (2023-12-01) -
Biomaterials and Cell-Based Regenerative Therapies for Intervertebral Disc Degeneration with a Focus on Biological and Biomechanical Functional Repair: Targeting Treatments for Disc Herniation
by: Katsuhisa Yamada, et al.
Published: (2022-02-01) -
Intervertebral disc degeneration and vertebral end plate damage in acute lumbar disc herniation
by: Arul P Nehru, et al.
Published: (2023-01-01) -
Biomarkers for intervertebral disc and associated back pain: From diagnosis to disease prognosis and personalized treatment
by: Catarina Leite Pereira, et al.
Published: (2023-12-01)